New Risk • Apr 01
New minor risk - Revenue size The company makes less than US$5m in revenue. Total revenue: ₩7.5b (US$5.0m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risks Revenue is less than US$5m (₩7.5b revenue, or US$5.0m). Market cap is less than US$100m (₩96.9b market cap, or US$64.3m). New Risk • Jan 03
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 31% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩97.2b market cap, or US$67.4m). Announcement • Dec 16
DEEPNOID Inc. has completed a Follow-on Equity Offering in the amount of KRW 19.720256 billion. DEEPNOID Inc. has completed a Follow-on Equity Offering in the amount of KRW 19.720256 billion.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 6,108,016
Price\Range: KRW 2885
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 727,428
Price\Range: KRW 2885
Transaction Features: Rights Offering New Risk • Nov 29
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -₩9.7b This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩9.7b free cash flow). Minor Risk Market cap is less than US$100m (₩87.7b market cap, or US$59.7m). Announcement • Sep 09
DEEPNOID Inc. has filed a Follow-on Equity Offering in the amount of KRW 27.000004 billion. DEEPNOID Inc. has filed a Follow-on Equity Offering in the amount of KRW 27.000004 billion.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 6,835,444
Price\Range: KRW 3950
Discount Per Security: KRW 35.55
Transaction Features: Rights Offering New Risk • Jul 04
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩136.2b (US$100.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩17b free cash flow). Minor Risks Share price has been volatile over the past 3 months (9.4% average weekly change). Market cap is less than US$100m (₩136.2b market cap, or US$100.0m). New Risk • Mar 28
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩141.7b (US$96.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩20b free cash flow). Minor Risks Share price has been volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$100m (₩141.7b market cap, or US$96.5m). Announcement • Mar 01
DEEPNOID Inc., Annual General Meeting, Mar 28, 2025 DEEPNOID Inc., Annual General Meeting, Mar 28, 2025, at 09:30 Tokyo Standard Time. Location: conference room, guro-gu, seoul South Korea Reported Earnings • Nov 15
Third quarter 2024 earnings released: ₩76.00 loss per share (vs ₩86.00 loss in 3Q 2023) Third quarter 2024 results: ₩76.00 loss per share. Revenue: ₩3.98b (up ₩3.49b from 3Q 2023). Net loss: ₩1.70b (loss widened 5.3% from 3Q 2023). Revenue is forecast to grow 46% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Healthcare Services industry in Asia. New Risk • Aug 02
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩125.8b (US$92.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding). Revenue is less than US$5m (₩2.1b revenue, or US$1.6m). Market cap is less than US$100m (₩125.8b market cap, or US$92.1m). New Risk • Nov 07
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 16% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risks Shareholders have been diluted in the past year (16% increase in shares outstanding). Revenue is less than US$5m (₩3.2b revenue, or US$2.5m). Announcement • Oct 26
DEEPNOID Inc. has completed a Follow-on Equity Offering in the amount of KRW 22.59 billion. DEEPNOID Inc. has completed a Follow-on Equity Offering in the amount of KRW 22.59 billion.
Security Name: Common Shares
Security Type: Common Stock
Securities Offered: 1,500,000
Price\Range: KRW 15060
Transaction Features: Subsequent Direct Listing Board Change • Nov 16
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Apr 27
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. 